Hookipa Pharma Delists Common Stock
Hookipa Pharma is delisting from Nasdaq and deregistering its common stock, a move closely tied to its recent asset...
i-Mab Strengthens Givastomig IP Portfolio Through Acquisition
I-Mab’s acquisition of Bridge Health Biotech signals a strategic move to solidify its position in the increasingly competitive Claudin...
Nicox & Kowa Sign €191.5M Glaucoma Deal for NCX 470
Nicox Secures Key Glaucoma Deal with Kowa, Reshaping its Future Nicox has licensed its nitric oxide-donating bimatoprost eye drop,...
Veraxa & Voyager Merger: Form F-4 Filed with SEC
Veraxa Biotech, an emerging player in next-generation antibody-based cancer therapies, has filed an F-4 registration statement with the SEC,...
Novartis Delivers Impressive Q2 Sales Growth, Raises FY2025 Guidance
Novartis Posts Strong Q2 2025 Results, Fueled by Key Product Launches and Strategic Acquisitions Novartis announced impressive double-digit growth...
nkgen Biotech Secures Funding to Regain Compliance
NKGen Biotech Secures $2 Million, Aiming for Nasdaq Return After Tumultuous Period NKGen Biotech, a clinical-stage company developing NK...
Avicana Closes Non-Brokered Private Placement
Avicanna Secures $1 Million in Private Placement, But Questions Linger About Long-Term Strategy Avicanna has closed a $1 million...
60 Degrees Pharmaceuticals Closes $10M Public Offering
60 Degrees Pharmaceuticals Bolsters Cash Runway with $5 Million Public Offering 60 Degrees Pharmaceuticals has closed a public offering,...
Tevogen.ai Awarded International AI Patent for Immunological Peptide Prediction
Tevogen Secures Key AI Patent, Signaling Broader Shift in Biopharma R&D Tevogen has secured a patent for its AI-driven...
Ioavance Biotherapeutics Announces Inducement Grants
Iovance Biotherapeutics, a prominent player in the burgeoning field of tumor-infiltrating lymphocyte (TIL) therapies, recently granted stock options to...